Replies to post #210002 on Biotech Values

[ghmm]

GNMX:

I was not too familiar with the company and did a quick listen to the call. The management team seemed full of explanations (aka excuses) a new one to me was the higher rate of weight gain one (of several) reason they attributed was the study being done over the holidays. Never heard that one before!

[DewDiligence]

GNMX raises $28M from PIPE:

http://www.prnewswire.com/news-releases/aevi-genomic-medicine-announces-agreement-for-28-million-private-placement-300502446.html

Aevi Genomic Medicine...today announced the execution of a definitive agreement to sell shares of common stock and warrants to purchase common stock in a private placement, or PIPE, to certain accredited investors, led by Children's Hospital of Philadelphia Foundation...

[DewDiligence]

CERC acquires GNMX for $0.134/sh in stock plus a CVR:

https://www.globenewswire.com/news-release/2019/12/05/1956803/0/en/Cerecor-to-Acquire-Aevi-Genomic-Medicine.html

This is a fire sale with no premium. The nominal deal value (excluding the CVR) is $16.1M.